title: Changes in the corrected QT interval and corrected QT dispersion during haemodialysis.
abstract: The link between increased QT dispersion and cardiac death in subjects with diabetes and arterial disease is well recognised. Corrected QT dispersion was studied in subjects with end stage renal failure on haemodialysis. Thirty one stable, chronic subjects on haemodialysis had 12-lead electrocardiograms (ECGs) taken before and after a single haemodialysis session. The QT interval was measured manually in each and the corrected QT and corrected QT dispersion calculated. Serum concentrations of potassium, calcium, and magnesium were measured at the same time as ECG acquisition. Corrected QT dispersion increased from a mean (SEM) 90.6 (5.8) to 117.7 (10.2) ms (p=0.002). Serum potassium and magnesium decreased from 5.0 (0.14) to 3.5 (0.09) mmol/l and 0.95 (0.04) to 0.89 (0.09) mmol/l respectively, while serum calcium increased from 2.56 (0.04) to 2.77 (0.04) mmol/l. Intradialytic weight fell by a mean of 2.1 kg. There was no significant correlation between the change in QTc dispersion and the changes in measured serum anions or the subjects' weight during dialysis. Corrected QT dispersion was higher in subjects on haemodialysis than previously suggested normal values, and was significantly increased by haemodialysis. This reflects increased inhomogeneous ventricular repolarisation, which may lead to an increased risk of arrhythmias and sudden death. Studies looking at QT dispersion in subjects on dialysis should standardise the timing of ECG recordings taken with respect to dialysis.
authors.affiliation: Department of Nephrology, Royal Liverpool University Hospital, Liverpool, UK. mlphowse@liverpool.ac.uk
authors.forename: M
authors.initials: M
authors.lastname: Howse
authors.forename: S
authors.initials: S
authors.lastname: Sastry
authors.forename: G M
authors.initials: GM
authors.lastname: Bell
mesh_terms: D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008133:Long QT Syndrome / Q000097:blood / Q000209:etiology*; D008274:Magnesium / Q000097:blood; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D008274:Magnesium; D011188:Potassium; D002118:Calcium